0001179110-15-000377.txt : 20150105
0001179110-15-000377.hdr.sgml : 20150105
20150105195515
ACCESSION NUMBER: 0001179110-15-000377
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150102
FILED AS OF DATE: 20150105
DATE AS OF CHANGE: 20150105
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: KYTHERA BIOPHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001436304
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 27200 WEST AGOURA ROAD
STREET 2: SUITE 200
CITY: CALABASAS
STATE: CA
ZIP: 91301
BUSINESS PHONE: 818-587-4500
MAIL ADDRESS:
STREET 1: 27200 WEST AGOURA ROAD
STREET 2: SUITE 200
CITY: CALABASAS
STATE: CA
ZIP: 91301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: David Nathaniel E
CENTRAL INDEX KEY: 0001559531
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35663
FILM NUMBER: 15507679
MAIL ADDRESS:
STREET 1: C/O KYTHERA BIOPHARMACEUTICALS, INC.
STREET 2: 27200 WEST AGOURA ROAD, SUITE 200
CITY: CALABASAS
STATE: CA
ZIP: 91301
4
1
edgar.xml
FORM 4 -
X0306
4
2015-01-02
0
0001436304
KYTHERA BIOPHARMACEUTICALS INC
KYTH
0001559531
David Nathaniel E
C/O KYTHERA BIOPHARMACEUTICALS, INC.
30930 RUSSELL RANCH ROAD, 3RD FLOOR
WESTLAKE VILLAGE
CA
91362
1
0
0
0
Common Stock
2015-01-02
4
S
0
1016
35.20
D
483781
D
Common Stock
2015-01-02
4
S
0
424
35.69
D
483357
D
Common Stock
2015-01-02
4
S
0
240
35.00
D
483117
D
The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan which expires April 30, 2015.
The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $34.61 to $35.54, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $35.59 to $35.80, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
/s/ Keith Klein, as Attorney-in-Fact for Nathaniel E. David
2015-01-05